Disease Info Card

Cleidocranial Dysplasia

Information about Cleidocranial Dysplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cleidocranial Dysplasia

Most recent studies have shown that Cleidocranial Dysplasia shares some biological mechanisms with albers-schonberg-disease, aplasia-nos, bone-diseases, bone-diseases-developmental, congenital-abnormality, cytogenetic-abnormality, dwarfism, dysostoses, dysplasia, exanthema, haploinsufficiency, hereditary-diseases, hypoplasia, impacted-tooth, leukemia, malocclusion, pycnodysostosis, skeletal-dysplasia, tooth-abnormalities, tooth-supernumerary.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cleidocranial Dysplasia, and have been seen in publications frequently: Bone Development, Bone Maturation, Bone Remodeling, Cell Cycle, Cell Differentiation, Cell Proliferation, Dehiscence, Endochondral Ossification, Intramembranous Ossification, Localization, Neurogenesis, Odontogenesis, Ossification, Osteoblast Differentiation, Parturition, Pathogenesis, Regulation Of Osteoblast Differentiation, Tooth Eruption, Translation, Transport

Quite a number of genes have been found to play important roles in Cleidocranial Dysplasia, such as A4GALT, ATP6V0A1, B3GALNT1, BGLAP, BMP2, CBFB, MSX2, PRF1, PRM1, RFC1, RFC2, RFC4, RUNX1, RUNX2, RUNX3, SHH, SPP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.